La Jolla

Synthetic biology company that created novel DNA base pairs and uses them to incorporate novel amino acids into proteins for potential therapeutics in areas of cancer and autoimmune disorders.

Anchored by our protein-engineering expertise and our proprietary single-domain antibody platform, we’ve developed a unique pipeline of therapeutic candidates.

Enlaza Therapeutics is pioneering the field of covalent biologics, developing a novel classes of protein therapeutics based on its proprietary War-Lock™ platform.

Alume Biosciences is developing nerve illumination technology, specifically bevonescein (ALM-488), to help surgeons protect and preserve nerve function during surgery by making nerves glow.

SYLKE® Skin Closure is a sterile, single-use, silk fibroin mesh strip with a pressure-sensitive adhesive intended for topical skin closure and wound support. The device is used to hold together well-approximated skin edges of a wound, and to cover and protect the wound. Learn more at sylke.com.

Spinogenix is pioneering first-in-class, investigational therapeutics that restore brain synapses to improve the lives of patients worldwide.

Paulex Bio stands at the threshold of what could be a transformative breakthrough for type 1 and type 2 diabetes: beta cell regeneration through an oral medicine designed to eliminate the root cause of diabetes.​

Model Medicines engineers first-in-class small molecules against biological choke points, using AI to advance pipeline-in-a-pill therapeutics across high-impact diseases.

We explore the immense therapeutic opportunities to help those bound by autoimmune neuropsychiatric diseases.

Valora Therapeutics is developing AbLec™ multispecific antibodies and T-Lec™ T cell engagers — antibody-engineering platforms that decoy the glyco-immune checkpoint to create best-in-class therapeutics for cancer and autoimmune disease.

Generate more event revenue with Events.com. Sell tickets online, promote your events, find sponsors, and grow your event business.

AeroRx Therapeutics is developing potential best-in-class nebulized combination therapies to improve COPD treatment.

Learn how Genomic Life enhances health and well-being through genetic screenings, early detection, personalized cancer navigation, and ongoing support. Optimize employee benefits and create a healthier workforce.

RightDevice was co-founded by George Kramb and Patrick Frank and later rebranded as PatientPartner, a platform connecting patients with medical device information and providers.

A28 Therapeutics is a clinical stage biopharmaceutical company developing a novel platform technology to treat multiple cancer types

Using Clinical Insights to Guide Patient Traffic Flow — DEPTH™ accelerates care velocity across the patient journey through Augmented Surveillance Intelligence.

Impulse Medical Technologies - A leading manufacturer and distributor of high-quality medical electrodes and diagnostic supplies. Parent company of The Electrode Store and TES Wholesale.

ViroMissile is developing the world’s first truly intravenously-delivered viruses that target and kill tumors.

TIGER HOSPITALITY - Elevating San Diego

Join The Mortgage Collaborative — a leading mortgage lender and preferred partner network helping mortgage professionals grow through collaboration, resources, and industry expertise.

Busa Beverage was conceptualized by the Busalacchi family, owners of the Barbusa restaurant in San Diego's Little Italy, and makes what it calls the first oat-milk bottled espresso martini.

Sarmal is developing proprietary single molecule DNA sequencing technology and target detection technology for genomic detection.